Page last updated: 2024-11-06

mitomycin and Bleeding

mitomycin has been researched along with Bleeding in 2 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to assess the risk of HCs after CRS combined with HIPEC-Ox versus other drugs, and to determine predictive factors for HCs after HIPEC-Ox."1.43Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors. ( Charrier, T; Cotte, E; Elias, D; Eveno, C; Glehen, O; Gocevska, S; Goere, D; Maurice, C; Ortega-Deballon, P; Passot, G; Peron, J; Pocard, M; Quénet, F; Vaudoyer, D, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Charrier, T1
Passot, G1
Peron, J1
Maurice, C1
Gocevska, S1
Quénet, F1
Eveno, C1
Pocard, M1
Goere, D1
Elias, D1
Ortega-Deballon, P1
Vaudoyer, D1
Cotte, E1
Glehen, O1
Zeller, G1
Wandel, E1
Schwarting, A1

Other Studies

2 other studies available for mitomycin and Bleeding

ArticleYear
Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors.
    Annals of surgical oncology, 2016, Volume: 23, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Region

2016
[Mitomycin-induced hemolytic-uremic syndrome].
    Deutsche medizinische Wochenschrift (1946), 2003, Jun-20, Volume: 128, Issue:25-26

    Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Hemolytic-Uremic Syndrome; Hemorrhage; Humans;

2003